Literature DB >> 27412628

Multifocal Versus Solitary Papillary Thyroid Carcinoma.

Andreas Kiriakopoulos1, Athanassios Petralias2, Dimitrios Linos3,4.   

Abstract

BACKGROUND: Papillary Thyroid Carcinoma (PTC) which accounts for >85 % of all thyroid cancers in iodine-rich areas, appears either as a single tumor or as two or more, neoplastic foci within the thyroid gland (Multifocal PTC). We present the comparative results between solitary and MFC PTC.
MATERIALS AND METHODS: Demographics, tumor characteristics (size, laterality, foci number, histologic subtype) and TNM staging were compared between solitary and MFPTC patients. The presence of lymphocytic or Hashimoto's thyroditis was also recorded.
RESULTS: From January 2008 to December 2012, among 647 PTC patients, 241(37.2 %) had MFPTC 177 females (73.4 %) and 64 males (26.6 %), mean age 48.5 years (range 12-87). Mean number of tumor foci was 3.3 (range 2-26). MFPTC patients presented with more advanced T stage (28.2 vs. 18.7 %, p = 0.01) and more LN metastases (28.6 vs. 15.5 %, p < 0.001). Foci number correlates with male gender and LN metastases (p = 0.014 and p = 0.019, respectively). Central (N1a) or lateral (N1b) LN involvement correlates strongly with male gender (p  = 0.024) and younger age (p < 0.001). The follicular variant was the next most frequent histologic subtype associated with extremely rare LN metastases.
CONCLUSION: MFPTC comprises a more aggressive form of papillary thyroid cancer since it is associated with more frequent N1a/ N1b disease and occurs more frequently in T3/T4 patients. MFPTC foci number correlates with male gender and LN metastases.

Entities:  

Mesh:

Year:  2016        PMID: 27412628     DOI: 10.1007/s00268-016-3628-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

2.  Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.

Authors:  Qunzi Zhao; Jie Ming; Chunping Liu; Lan Shi; Xia Xu; Xiu Nie; Tao Huang
Journal:  Ann Surg Oncol       Date:  2012-09-13       Impact factor: 5.344

Review 3.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

Authors:  Louise Davies; Luc G T Morris; Megan Haymart; Amy Y Chen; David Goldenberg; John Morris; Jennifer B Ogilvie; David J Terris; James Netterville; Richard J Wong; Gregory Randolph
Journal:  Endocr Pract       Date:  2015-06       Impact factor: 3.443

4.  Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

Authors:  So Yeon Park; Young Joo Park; Yu Jin Lee; Hyun Sook Lee; Sung Hee Choi; Gheeyoung Choe; Hak-Chul Jang; Seong Hoe Park; Do Joon Park; Bo Youn Cho
Journal:  Cancer       Date:  2006-10-15       Impact factor: 6.860

5.  Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.

Authors:  Ian D Hay; Maeve E Hutchinson; Tomas Gonzalez-Losada; Bryan McIver; Megan E Reinalda; Clive S Grant; Geoffrey B Thompson; Thomas J Sebo; John R Goellner
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

6.  High recurrent rate of multicentric papillary thyroid carcinoma.

Authors:  Jen-Der Lin; Tzu-Chieh Chao; Chuen Hsueh; Sheng-Fong Kuo
Journal:  Ann Surg Oncol       Date:  2009-06-16       Impact factor: 5.344

Review 7.  Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

8.  Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia.

Authors:  S L Sugg; S Ezzat; I B Rosen; J L Freeman; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.

Authors:  L Jovanovic; B Delahunt; B McIver; N L Eberhardt; S K G Grebe
Journal:  J Pathol       Date:  2008-06       Impact factor: 7.996

10.  Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus.

Authors:  Mikhail V Fridman; Natallia N Savva; Olga V Krasko; Anna A Zborovskaya; Svetlana V Mankovskaya; Kurt Werner Schmid; Yuri E Demidchik
Journal:  Thyroid       Date:  2012-09-04       Impact factor: 6.568

View more
  10 in total

1.  Multifocal Versus Solitary Papillary Thyroid Carcinoma.

Authors:  Sapana Bothra; Sabaretnam Mayilvaganan
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

2.  Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden.

Authors:  Jacopo Manso; Simona Censi; Amir Roberti; Maurizio Iacobone; Susi Barollo; Loris Bertazza; Francesca Galuppini; Federica Vianello; Nora Albinger; Carla Scaroni; Gianmaria Pennelli; Caterina Mian
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-12       Impact factor: 3.565

3.  Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma.

Authors:  Hui Huang; Shaoyan Liu; Zhengang Xu; Song Ni; Zongmin Zhang; Xiaolei Wang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

4.  Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors.

Authors:  Soh-Ching Ng; Sheng-Fong Kuo; Szu-Tah Chen; Chuen Hsueh; Bie-Yu Huang; Jen-Der Lin
Journal:  Int J Endocrinol       Date:  2017-05-31       Impact factor: 3.257

5.  Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience.

Authors:  Shuai Xue; Peisong Wang; Jia Liu; Guang Chen
Journal:  World J Surg Oncol       Date:  2017-03-16       Impact factor: 2.754

6.  A Rare Case of Multifocal Papillary Thyroid Cancer in Bilateral Thyroid Cysts.

Authors:  Anupama Roy Chowdhury; Jack Kian Ch'ng; Choon Chieh Tan
Journal:  Case Rep Med       Date:  2018-04-17

7.  Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.

Authors:  Jia-Wei Feng; Jing Ye; Wan-Xiao Wu; Hua Pan; An-Cheng Qin; Yong Jiang; Bao-Qiang Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-08       Impact factor: 5.555

8.  Association between Thyroiditis and Multifocality in Papillary Thyroid Carcinoma.

Authors:  Rogério Aparecido Dedivitis; Leandro Luongo de Matos; Felipe Guilherme Silva Souza; Jose Luis Bogado Ortiz
Journal:  Int Arch Otorhinolaryngol       Date:  2020-06-23

9.  Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.

Authors:  Li Genpeng; Lei Jianyong; You Jiaying; Jiang Ke; Li Zhihui; Gong Rixiang; Zhang Lihan; Zhu Jingqiang
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

Review 10.  Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.

Authors:  Natalia Pstrąg; Katarzyna Ziemnicka; Hans Bluyssen; Joanna Wesoły
Journal:  Mol Cancer       Date:  2018-08-08       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.